Rwanda health authorities will launch a vaccine study to counter the Marburg hemorrhagic fever outbreak, which has already claimed 12 lives. The Sabin Vaccine Institute provided 700 trial doses targeting health workers and contacts of confirmed cases.

Rwanda begins vaccine trials amid fears of outbreak of deadly disease - Virus kills around half of people it infects

Health officials in Rwanda are dealing with the country’s first outbreak of the Marburg virus, an Ebola-like disease which, if left untreated, has a fatality rate of up to 88%.

German police cordoned off part of a train station in Hamburg and isolated two people to reduce the risk of the deadly Marburg virus spreading.

The East African country continues to investigate the source of the outbreak, first traced among patients in health facilities.

In Rwanda, 11 deaths have been reported from this rare but deadly disease. Two people tested negative in Germany this week.

Rwandan health authorities are struggling to contain the outbreak of the deadly Marburg virus, which has claimed the lives of about a dozen people. Health Minister Sabin Nsanzimana said those infected are mostly healthcare workers who are usually the first responders.

While outbreaks of Marburg virus are rare, there have been several in recent years across sub-Saharan Africa. It's one of the deadliest viral diseases and can be fatal. Here's what you need to know.